Skip to main content
SpringerLink
Log in

Quantitative analysis of matrix metalloproteinase-2 mRNA expression in central and peripheral regions of gliomas

  • Original Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

Malignant gliomas are characterized by their invasiveness and angiogenesis. Matrix metalloproteinases (MMPs) degrade extracellular matrix and create a more permissive environment for cell invasion. We aimed to investigate for the presence of inter- and intratumoral heterogeneity in MMP-2 messenger RNA (mRNA) expression by means of quantitative analysis and to evaluate its prognostic impact in glioma patients. Representative sections from the center and periphery of tumors resected en bloc were taken fresh for study, stained with hematoxylin/eosin for histological evaluation, and immunohistochemically analyzed for Ki-67. MMP-2 mRNA expression was evaluated by real-time reverse transcriptase polymerase chain reaction (RT-PCR). There was MMP-2 expression in all analyzed tumors. By topographical dissection of surgical specimens, we found no differences in cell proliferation or density but significant differences with regard to MMP-2 mRNA expression between central and peripheral regions, being highest at the center of malignant gliomas. MMP-2 mRNA expression showed no prognostic influence on overall or disease-free survival. Our results demonstrate that MMP-2 is differentially expressed in central and peripheral regions of gliomas. Further studies are necessary to clarify the significance of these findings and their possible relevance in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bellail AC, Hunter SB, Brat DJ et al (2004) Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. Int J Biochem Cell Biol 36:1046–1069

    Article  PubMed  CAS  Google Scholar 

  2. Gabelloni P, Da PE, Bendinelli S et al (2010) Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma. Neuroscience 168:514–522

    Article  PubMed  CAS  Google Scholar 

  3. Jaalinoja J, Herva R, Korpela M et al (2000) Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms. J Neurooncol 46:81–90

    Article  PubMed  CAS  Google Scholar 

  4. Van MT, Dumur C, Hafez N et al (2006) Microarray analysis of MRI-defined tissue samples in glioblastoma reveals differences in regional expression of therapeutic targets. Diagn Mol Pathol 15:195–205

    Article  Google Scholar 

  5. Hoelzinger DB, Mariani L, Weis J et al (2005) Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 7:7–16

    Article  PubMed  CAS  Google Scholar 

  6. Bello L, Lucini V, Carrabba G et al (2001) Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 61:8730–8736

    PubMed  CAS  Google Scholar 

  7. Park CK, Jung JH, Park SH et al (2009) Multifarious proteomic signatures and regional heterogeneity in glioblastomas. J Neurooncol 94:31–39

    Article  PubMed  Google Scholar 

  8. D’Abaco GM, Kaye AH (2007) Integrins: molecular determinants of glioma invasion. J Clin Neurosci 14:1041–1048

    Article  PubMed  Google Scholar 

  9. Deryugina EI, Bourdon MA, Luo GX et al (1997) Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 110:2473–2482

    PubMed  CAS  Google Scholar 

  10. Nisato RE, Hosseini G, Sirrenberg C et al (2005) Dissecting the role of matrix metalloproteinases (MMP) and integrin alpha(v)beta3 in angiogenesis in vitro: absence of hemopexin C domain bioactivity, but membrane-Type 1-MMP and alpha(v)beta3 are critical. Cancer Res 65:9377–9387

    Article  PubMed  CAS  Google Scholar 

  11. Brooks PC, Stromblad S, Sanders LC et al (1996) Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85:683–693

    Article  PubMed  CAS  Google Scholar 

  12. Ozen O, Krebs B, Hemmerlein B et al (2004) Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance. Clin Cancer Res 10:4746–4753

    Article  PubMed  Google Scholar 

  13. Baumann F, Leukel P, Doerfelt A et al (2009) Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncol 11:368–380

    Article  PubMed  CAS  Google Scholar 

  14. Bello L, Francolini M, Marthyn P et al (2001) Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery 49:380–389

    Article  PubMed  CAS  Google Scholar 

  15. Du R, Petritsch C, Lu K et al (2008) Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. Neuro Oncol 10:254–264

    Article  PubMed  CAS  Google Scholar 

  16. Kong L, Li Q, Wang L et al (2007) The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas. Neuropathology 27:516–521

    Article  PubMed  Google Scholar 

  17. Komatsu K, Nakanishi Y, Nemoto N et al (2004) Expression and quantitative analysis of matrix metalloproteinase-2 and -9 in human gliomas. Brain Tumor Pathol 21:105–112

    Article  PubMed  CAS  Google Scholar 

  18. Santandreu FM, Brell M, Gene AH et al (2008) Differences in mitochondrial function and antioxidant systems between regions of human glioma. Cell Physiol Biochem 22:757–768

    Article  PubMed  CAS  Google Scholar 

  19. Tate MC, Aghi MK (2009) Biology of angiogenesis and invasion in glioma. Neurotherapeutics 6:447–457

    Article  PubMed  CAS  Google Scholar 

  20. Raithatha SA, Muzik H, Muzik H et al (2000) Localization of gelatinase-A and gelatinase-B mRNA and protein in human gliomas. Neuro Oncol 2:145–150

    PubMed  CAS  Google Scholar 

  21. Wang M, Wang T, Liu S et al (2003) The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol 20:65–72

    Article  PubMed  Google Scholar 

  22. Kleihues P, Louis DN, Wiestler OD et al (2007) WHO grading of tumors of the central nervous system. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) The WHO Classification of Tumors of the Central Nervous System, 4th edn. International Agency for Research on Cancer (IARC), Lyon, pp 10–11

    Google Scholar 

  23. Going JJ (1994) Efficiently estimated histologic cell counts. Hum Pathol 25:333–336

    Article  PubMed  CAS  Google Scholar 

  24. Larionov A, Krause A, Miller W (2005) A standard curve based method for relative real time PCR data processing. BMC Bioinform 21:62

    Article  Google Scholar 

  25. Tchirkov A, Rolhion C, Kemeny JL et al (2003) Clinical implications of quantitative real-time RT–PCR analysis of hTERT gene expression in human gliomas. Br J Cancer 88:516–520

    Article  PubMed  CAS  Google Scholar 

  26. Valente V, Teixeira SA, Neder L et al (2009) Selection of suitable housekeeping genes for expression analysis in glioblastoma using quantitative RT-PCR. BMC Mol Biol 10:17

    Article  PubMed  Google Scholar 

  27. Pluderi M, Lucini V, Caronzolo D et al (2003) Long-term inhibition of glioma growth by systemic administration of human PEX. J Neurosurg Sci 47:69–78

    PubMed  CAS  Google Scholar 

  28. Park MH, Ahn BH, Hong YK et al (2009) Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways. Carcinogenesis 30:356–365

    Article  PubMed  CAS  Google Scholar 

  29. Zhou YH, Hess KR, Liu L et al (2005) Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables. Neuro Oncol 7:485–494

    Article  PubMed  CAS  Google Scholar 

  30. Yano H, Hara A, Murase S et al (2001) Expression of hepatocyte growth factor and matrix metalloproteinase-2 in human glioma. Brain Tumor Pathol 18:7–12

    Article  PubMed  CAS  Google Scholar 

  31. Walker C, du Plessis DG, Joyce KA et al (2003) Phenotype versus genotype in gliomas displaying inter- or intratumoral histological heterogeneity. Clin Cancer Res 9:4841–4851

    PubMed  CAS  Google Scholar 

  32. VanMeter TE, Rooprai HK, Kibble MM et al (2001) The role of matrix metalloproteinase genes in glioma invasion: Co-dependent and interactigve proteolysis. J Neurooncol 53:213–235

    Article  PubMed  CAS  Google Scholar 

  33. Guo P, Imanishi Y, Cackowski FC et al (2005) Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am J Pathol 166:877–890

    Article  PubMed  CAS  Google Scholar 

  34. Takano S, Tsuboi K, Matsumura A et al (2001) Localization of gelatinase activities in glioma tissues by film in situ zymography. Brain Tumor Pathol 18:145–150

    Article  PubMed  CAS  Google Scholar 

  35. Trog D, Yeghiazaryan K, Fountoulakis M et al (2006) Pro-invasive gene regulating effect of irradiation and combined temozolomide-radiation treatment on surviving human malignant glioma cells. Eur J Pharmacol 542:8–15

    Article  PubMed  CAS  Google Scholar 

  36. Kunishio K, Okada M, Matsumoto Y et al (2003) Matrix metalloproteinase-2 and -9 expression in astrocytic tumors. Brain Tumor Pathol 20:39–45

    Article  PubMed  CAS  Google Scholar 

  37. Pagenstecher A, Wussler EM, Opdenakker G et al (2001) Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors. J Neuropathol Exp Neurol 60:598–612

    PubMed  CAS  Google Scholar 

  38. Aaberg-Jessen C, Christensen K, Offenberg H et al (2009) Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival. J Neurooncol 95:117–128

    Article  PubMed  CAS  Google Scholar 

  39. Silveira Correa TC, Massaro RR, Brohem CA et al (2010) RECK-mediated inhibition of glioma migration and invasion. J Cell Biochem 110:52–61

    PubMed  CAS  Google Scholar 

  40. Fillmore HL, VanMeter TE, Broaddus WC (2001) Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion. J Neurooncol 53:187–202

    Article  PubMed  CAS  Google Scholar 

  41. Figueira RC, Gomes LR, Neto JS et al (2009) Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer 9:20

    Article  PubMed  Google Scholar 

  42. Noda M, Oh J, Takahashi R et al (2003) RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev 22:167–175

    Article  PubMed  CAS  Google Scholar 

  43. Dunn J, Baborie A, Alam F et al (2009) Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Br J Cancer 101:124–131

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the Ministerio de Sanidad y Consumo FIS 07/1269.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, HUSD, Palma de Mallorca, Spain

    Marta Brell & Javier Ibáñez

  2. Research Unit, HUSD, Palma de Mallorca, Spain

    Ana Felpete, Bartolome Burguera & Marga Frontera

  3. Department of Pathology, HUSD, Palma de Mallorca, Spain

    Marta E. Couce

Authors
  1. Marta Brell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Javier Ibáñez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ana Felpete
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bartolome Burguera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marga Frontera
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marta E. Couce
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marta E. Couce.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brell, M., Ibáñez, J., Felpete, A. et al. Quantitative analysis of matrix metalloproteinase-2 mRNA expression in central and peripheral regions of gliomas. Brain Tumor Pathol 28, 137–144 (2011). https://doi.org/10.1007/s10014-011-0021-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10014-011-0021-9

Keywords

Search

Navigation